Zydus Cadila gets final US FDA approval to market acne drug

The drug will be manufactured at the group’s topical manufacturing facility at Ahmedabad

Zydus Cadila has received the final nod from the US health regulator to market Clindamycin Phosphate and Benzoyl Peroxide gel, used in the treatment of acne.

This combination medication is used to treat a certain type of acne (inflammatory acne vulgaris), the company said in a BSE filing. It also helps to decrease the number of acne pimples.

“Zydus Cadila has received the final approval from the US FDA to market Clindamycin Phosphate and Benzoyl Peroxide Gel, (US RLD DUAC Gel), 1.2 per cent/5 per cent. It will be manufactured at the group’s topical manufacturing facility at Ahmedabad,” it added.